INO logo

INO

Inovio Pharmaceuticals Inc.

$2.37
-$0.09(-3.66%)
27
Overall
--
Value
18
Tech
36
Quality
Market Cap
$108.41M
Volume
1.20M
52W Range
$1.30 - $7.22
Target Price
$7.47
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$40.6M$35.2M$42.2M$30.5M$4.1M$7.4M$1.8M$10.3M$832.0K$217.8K
Total Revenue
$40.6M$35.4M$42.2M$30.5M$4.1M$7.4M$1.8M$10.3M$832.0K$217.8K
GROSS PROFIT
Gross Profit
$40.6M$35.2M$42.2M$30.5M$4.1M$7.4M$1.8M$10.3M$832.0K$217.8K
OPERATING EXPENSES
Operating Expenses
$-74.9M$-111.6M$126.9M$124.6M$115.2M$131.5M$303.0M$277.8M$144.8M$112.6M
Research & Development
$57.8M$88.7M$98.6M$95.3M$88.0M$94.2M$249.2M$187.7M$86.7M$75.6M
Research Expense
$57.8M$88.7M$98.6M$95.3M$88.0M$94.2M$249.2M$187.7M$86.7M$75.6M
Selling, General & Administrative
$18.1M$23.9M$28.3M$29.3M$27.2M$37.2M$53.8M$90.2M$47.6M$37.0M
General & Administrative Expenses
$18.1M$23.9M$28.3M$29.3M$27.2M$37.2M$53.8M$90.2M$47.6M$37.0M
Salaries & Wages
$-6.2M$-10.5M$-13.1M$-10.7M$10.9M$15.6M$26.3M--$10.4M$6.4M
Depreciation & Amortization
$-1.0M$-1.7M$-1.9M$-3.7M$3.6M$3.0M$3.0M$3.7M$2.6M$1.8M
Depreciation & Amortization
$-1.0M$-1.7M$-1.9M$-3.7M$3.6M$3.0M$3.0M$3.7M$2.6M$1.8M
Amortization
$-870.2K$-1.4M$-1.6M$-1.2M$10.5M$10.5M$10.5M$10.5M----
Other Operating Expenses
$-74.9M$-111.6M$-125.9M$-124.6M$-1.6M$-1.0M$-6.6M$-2.9M$-1.8M$-2.3M
OPERATING INCOME
Operating income
$-35.3M$-77.4M$-84.6M$-94.1M$-111.1M$-124.1M$-301.2M$-267.6M$-143.9M$-112.4M
EBITDA
$-28.9M$-70.4M$-84.4M$-89.7M$-107.3M$-149.6M$-296.6M$-270.9M$-135.6M$-105.6M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
--------$7.9M$8.7M$1.9M$1.3M$1.2M--
Interest Income Operating
------$2.3M$2.6M$3.3M$3.4M$4.8M$8.1M--
Intinc
$305.1K$1.3M$1.6M----------$8.1M$4.8M
Net Non-Operating Interest Income/Expense
$2.9M$1.3M$1.6M$360.8K$-7.9M$-8.7M$-1.9M$-3.5M$8.1M$4.8M
Gain on Sale of Securities
$151.0K$139.0K--$20.0K$-1.8M$-75.7M$394.0K$21.0K$1.0K$900
Other Income/Expense
$-1.2M$-2.1M$5.2M$3.3M$1.3M$75.1M$3.3M$-13.6M$-1.2M$-1.7M
Other Special Charges
$-722.0K$1.1M$14.8M$-3.3M$496.2K$-704.9K$343.4K$-3.9M$-4.7M$-355.1K
SPECIAL ITEMS
Special Income Charges
----$215.0K$1.3M--------$-10.5M--
Impairment of Capital Assets
----------------$10.5M--
PRE-TAX INCOME
EBIT
$-31.2M$-73.7M$-88.2M$-94.8M$-112.9M$-154.2M$-301.3M$-276.4M$-139.0M$-108.8M
Pre-Tax Income
$-31.2M$-73.7M$-88.2M$-94.8M$-120.8M$-162.9M$-303.2M$-277.7M$-134.6M$-107.3M
INCOME TAX
Tax Provision
$-2.1M$-501.0K$-50.0M$2.2M$-257.3K--$-3.4M$-3.6M$-3.9M$-1.5M
NET INCOME
Net Income
$-29.2M$-74.1M$-88.2M$-97.0M$-119.4M$-166.4M$-303.7M$-279.8M$-135.1M$-107.3M
Net Income (Continuing Operations)
$-29.2M$-74.1M$-88.2M$-97.0M$-119.4M$-166.4M$-303.7M$-279.8M$-135.1M$-107.3M
Net Income (Discontinued Operations)
$-29.2M$-74.1M$-88.2M$-97.0M$-119.4M$-166.4M$-303.7M$-279.8M$-135.1M$-107.3M
Net Income (Common Stockholders)
$-29.2M$-74.1M$-88.2M$-97.0M$-116.3M$-166.4M$-303.7M$-279.8M$-135.1M$-107.3M
Normalized Income
------------------$-107.5M
TOTALS
Total Expenses
$-74.9M$-111.6M$126.9M$124.6M$115.2M$131.5M$303.0M$277.8M$144.8M$112.6M
SHARE & EPS DATA
Average Shares Outstanding
$68.2M$73.2M$81.8M$92.5M$98.7M$12.9M$17.4M$19.9M$22.2M$27.2M
Average Shares Outstanding (Diluted)
$68.4M$73.2M$81.9M$92.5M$98.7M$12.9M$17.4M$19.9M$22.2M$27.2M
Shares Outstanding
$72.2M$74.1M$90.4M$97.6M$145.8M$17.3M$18.1M$21.7M$23.4M$36.7M
Basic EPS
$-0.43$-1.01$-1.08$-1.05$-1.21$-12.84$-17.4$-14.04$-6.09$-3.95
Basic EPS (Continuing Operations)
----$-1.08$-1.05$-1.21$-12.84$-17.4$-14.04$-6.09$-3.95
Diluted EPS
$-0.44$-1.01$-1.09$-1.05$-1.21$-12.84$-17.4$-14.04$-6.09$-3.95
Diluted EPS (Continuing Operations)
----$-1.09$-1.05$-1.21--$-17.4$-14.04$-6.09$-3.95
OTHER METRICS
Acquired In Process Rn D
----$-7.0M--------------
Earnings from equity interest
----$-7.0M----$-4.6M$-434.4K$-2.2M----
Earnings From Equity Interest Net Of Tax
----$-7.0M----$-4.6M$-434.4K$-2.2M----
Gain On Sale Of Business
$2.6M--------$4.1M--------
Gain On Sale Of P P E
$1.0M$1.0M$1.0M--$6.0K$227.0K$89.0K$1.1M$466.0K$37.0K
Minority Interests
$-84.8K------$1.2M$1.1M--------
Other Gand A
$18.1M$23.9M$28.3M$29.3M$27.2M$37.2M$53.8M$90.2M$47.6M$37.0M
Other Impairment Of Capital Assets
$-274.0K------------------
Realized Capital Gain
------$-2.0M------------
Rent And Landing Fees
$18.1M$23.9M$-2.4M--------------
Write Down
----$-215.0K--------------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2INO$2.37-3.7%1.20M
3
4
5
6

Get Inovio Pharmaceuticals Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.